Pyrano[4,3-b]indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD)
US-12502376-B2 · Dec 23, 2025 · US
This page is not indexed by search engines while we improve data quality.
Maxwell John Patrick patents
Maxwell John Patrick is listed as an inventor on 54 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Maxwell John Patrick |
| Total patents | 54 |
| First publication | Apr 23, 2015 |
| Latest publication | Dec 23, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Modulators of alpha-1 antitrypsin
US-12331057-B2 · Jun 17, 2025 · US
Quinoxalinone compounds, compositions, methods, and kits for increasing genome editing efficiency
US-12269804-B2 · Apr 8, 2025 · US
Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitors
US-12251387-B2 · Mar 18, 2025 · US
Modulators of alpha-1 antitrypsin
US-2024336614-A1 · Oct 10, 2024 · US
DNA-PK inhibitors
US-12005127-B2 · Jun 11, 2024 · US
Modulators of alpha-1 antitrypsin
US-11884672-B2 · Jan 30, 2024 · US
DNA-PK inhibitors
US-11813267-B2 · Nov 14, 2023 · US
Modulators of alpha-1 antitrypsin
US-2023339915-A1 · Oct 26, 2023 · US
Substituted quinoxaline dna-pk inhibitors
US-2023277547-A1 · Sep 7, 2023 · US
Recent patents
Latest publications not already listed above.
Modulators of alpha-1 antitrypsin
US-2023265080-A1 · Aug 24, 2023 · US
1h-pyrazolo[4,3-g]isoquinoline and 1h-pyrazolo[4,3-g]quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)
US-2023159521-A1 · May 25, 2023 · US
Pyrano[4,3-b]indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)
US-2023157999-A1 · May 25, 2023 · US
Indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)
US-2023159502-A1 · May 25, 2023 · US
7- or 8-hydroxy-isoquinoline and 7- or 8-hydroxy-quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)
US-2023159504-A1 · May 25, 2023 · US
Pyrrolo[2,3-f]indazole and 2,4,5,10-tetrazatricyclo[7.3.0.03,7]dodeca-1,3(7),5,8,11-pentaene derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)
US-2023159580-A1 · May 25, 2023 · US
Modulators of alpha-1 antitrypsin
US-11623924-B2 · Apr 11, 2023 · US
Substituted quinoxaline dna-pk inhibitors
US-2021236505-A1 · Aug 5, 2021 · US
Modulators of alpha-1 antitrypsin
US-2021179587-A1 · Jun 17, 2021 · US
DNA-PK inhibitors
US-11021465-B2 · Jun 1, 2021 · US
DNA-PK inhibitors
US-11008305-B2 · May 18, 2021 · US
Substituted quinoxaline DNA-PK inhibitors
US-10973830-B2 · Apr 13, 2021 · US
Dna-pk inhibitors
US-2021069203-A1 · Mar 11, 2021 · US
Modulators of alpha-1 antitrypsin
US-2020361939-A1 · Nov 19, 2020 · US
Quinoxalinone compounds, compositions, methods, and kits for increasing genome editing efficiency
US-2020361877-A1 · Nov 19, 2020 · US
Dna-pk inhibitors
US-2020353101-A1 · Nov 12, 2020 · US
DNA-PK inhibitors
US-10786512-B2 · Sep 29, 2020 · US
Dna-pk inhibitors
US-2020109130-A1 · Apr 9, 2020 · US
Dna-pk inhibitors
US-2020062732-A1 · Feb 27, 2020 · US
DNA-PK inhibitors
US-10501439-B2 · Dec 10, 2019 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Vertex Pharma | 54 |
| Obligated Assignee | 1 |
| Vertex Pharamceuticals Incorporated | 1 |
| Vertex Pharmaceutical Incorporated | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K31/5377 | 47 |
| C07D487/04 | 44 |
| A61P35/00 | 43 |
| C07D403/12 | 41 |
| C07D405/14 | 41 |